# MRI in Renal Tumors

> **NCT02325921** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 39 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DEVICE:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT02325921
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2020-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02325921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02325921, "MRI in Renal Tumors". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02325921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*